Biomarker signatures correlate with clinical outcome in refractory metastatic colorectal cancer patients receiving bevacizumab and everolimus.
about
Insulin growth factor binding protein 2 mediates the progression of lymphangioleiomyomatosis.Correlation Between IGFs-Related Proteins Expression and Incidence of Colorectal Cancer in Diabetic Patients and Related Mechanisms.Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients.
P2860
Biomarker signatures correlate with clinical outcome in refractory metastatic colorectal cancer patients receiving bevacizumab and everolimus.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Biomarker signatures correlate ...... ng bevacizumab and everolimus.
@en
type
label
Biomarker signatures correlate ...... ng bevacizumab and everolimus.
@en
prefLabel
Biomarker signatures correlate ...... ng bevacizumab and everolimus.
@en
P2093
P921
P1476
Biomarker signatures correlate ...... ng bevacizumab and everolimus.
@en
P2093
Andrew B Nixon
Anthony Amara
Anuradha Bulusu
Christel Rushing
Herbert I Hurwitz
Hope E Uronis
Ivy Altomare
John C Brady
Mark D Starr
Wanda Honeycutt
P304
P356
10.1158/1535-7163.MCT-14-0923-T
P50
P577
2015-02-18T00:00:00Z